Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Simon

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Antimicrobial Chemotherapy|March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartmentsBasma Abdi, Mouna Chebbi, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2012
Risk factors for raltegravir resistance development in clinical practiceIsabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
International Journal of Antimicrobial Agents|September 22, 2018
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencingThuy Nguyen, Sepideh Akhavan, Fabienne Caby, et al.
Neurobiology of Disease|September 20, 2017
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous systemGemma Llufriu-Dabén, Alex Carrete, Elena Chierto, et al.
The Journal of Antimicrobial Chemotherapy|October 2, 2014
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypesDjeneba B Fofana, Charlotte Charpentier, Almoustapha I Maïga, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategiesEve Todesco, Sophie Sayon, Slim Fourati, et al.
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
Antiviral Therapy|December 19, 2002
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trialVincent Calvez, Dominique Costagliola, Diane Descamps, et al.
Annals of Clinical Microbiology and Antimicrobials|January 7, 2021
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in BeninCarine Yehouenou, Bert Bogaerts, Kevin Vanneste, et al.
International Journal of Antimicrobial Agents|October 8, 2010
In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapyMickaël Riou, Sylviane Carbonnelle, Laëtitia Avrain, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Antimicrobial Chemotherapy|March 11, 2021
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartmentsBasma Abdi, Mouna Chebbi, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2012
Risk factors for raltegravir resistance development in clinical practiceIsabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
International Journal of Antimicrobial Agents|September 22, 2018
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencingThuy Nguyen, Sepideh Akhavan, Fabienne Caby, et al.
Neurobiology of Disease|September 20, 2017
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous systemGemma Llufriu-Dabén, Alex Carrete, Elena Chierto, et al.
The Journal of Antimicrobial Chemotherapy|October 2, 2014
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypesDjeneba B Fofana, Charlotte Charpentier, Almoustapha I Maïga, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2013
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategiesEve Todesco, Sophie Sayon, Slim Fourati, et al.
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
Antiviral Therapy|December 19, 2002
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trialVincent Calvez, Dominique Costagliola, Diane Descamps, et al.
Annals of Clinical Microbiology and Antimicrobials|January 7, 2021
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in BeninCarine Yehouenou, Bert Bogaerts, Kevin Vanneste, et al.
International Journal of Antimicrobial Agents|October 8, 2010
In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapyMickaël Riou, Sylviane Carbonnelle, Laëtitia Avrain, et al.
Pageof 17